All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

312

Reset

312 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • ABC008UlviprubartPhase 33 trials

    Abcuro, Inc. · Inclusion Body Myositis (IBM), Inclusion Body Myositis, T-cell Large Granular Lymphocytic Leukemia

  • BezuclastinibCGT9486, PLX9486Phase 33 trials

    Cogent Biosciences, Inc. · Advanced Systemic Mastocytosis (AdvSM), SM With an Associated Hematologic Neoplasm (SM-AHN), Mast Cell Leukemia (MCL)

  • BIVV001efanesoctocog, AltuvoctPhase 33 trials

    Swedish Orphan Biovitrum · Haemophilia A (Moderate or Severe), Hemophilia A, Hemophilia A, Severe

  • bypassing agentsClotting factor concentrates, CFCPhase 33 trials

    Sanofi · Hemophilia, Von Willebrand Disease, Type 3

  • CyclophosphamidPhase 33 trials

    Alentis Therapeutics AG · Glomerulonephritis Rapidly Progressive, Diffuse Large B-Cell Lymphoma (DLBCL), Metastatic Colorectal Cancer

  • ESAErythropoiesis-Stimulating AgentPhase 33 trials

    Kind Pharmaceuticals LLC · Anemia Due to Chronic Kidney Disease, Anemia of Chronic Kidney Disease

  • FRSW107Phase 33 trials

    Hangzhou Gensciences Biopharmaceutical Co., Ltd. · Severe Hemophilia A

  • NSC 613327Phase 33 trials

    BeBetter Med Inc · Locally Advanced Triple-negative Breast Cancer, Metastatic Triple-negative Breast Cancer, Relapsed/Refractory Diffuse Large B-Cell Lymphoma

  • NX-5948bexobrutidegPhase 33 trials

    Nurix Therapeutics, Inc. · B-cell Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

  • RadotinibSupect, IY5511Phase 33 trials

    Il-Yang Pharm. Co., Ltd. · Chronic Myeloid Leukemia, Chronic Phase, CML, Chronic Phase, CML, Refractory

  • SG301Phase 33 trials

    Hangzhou Sumgen Biotech Co., Ltd. · Systemic Lupus Erythematosus (SLE), Relapsed/Refractory Multiple Myeloma, Antibody Mediated Rejection

  • TAK-755rADAMTS13, recombinant ADAMTS13Phase 33 trials

    Takeda · Thrombotic Thrombocytopenic Purpura (TTP), Acute Ischemic Stroke

  • TirabrutinibONO-4059Phase 33 trials

    Ono Pharmaceutical Co., Ltd. · Pemphigus, Steroid-resistant Pemphigus, Relapsed/Refractory Primary Central Nervous System Lymphoma

  • TQB2825Phase 33 trials

    Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. · Follicular Lymphoma, Diffuse Large B Cell Lymphoma, Diffuse Large Cell B-lymphoma

  • Zola-celBMS-986353, CC-97540Phase 33 trials

    Bristol Myers Squibb · Systemic Sclerosis, Lupus Erythematosus, Systemic, Lupus Nephritis

  • Arlocabtagene AutoleucelBMS-986393, GPRC5D CAR T cellsPhase 32 trials

    Bristol Myers Squibb · Multiple Myeloma, Relapsed or Refractory Multiple Myeloma (RRMM)

  • bb2121BMS-986395Phase 32 trials

    Bristol Myers Squibb · Multiple Myeloma

  • BCD-248Phase 32 trials

    Biocad · Relapsed/Refractory Multiple Myeloma, Myeloma Multiple

  • BL-8040Phase 32 trials

    BioLineRx, Ltd. · Multiple Myeloma, Pancreatic Adenocarcinoma

  • BL-M11D1Phase 32 trials

    Sichuan Baili Pharmaceutical Co., Ltd. · Acute Myeloid Leukemia, Myelodysplastic Syndromes

  • BleximenibJNJ-75276617Phase 32 trials

    Johnson & Johnson (Janssen) · Acute Leukemia, Leukemia, Myeloid, Acute

  • ClifutinibHEC73543Phase 32 trials

    Sunshine Lake Pharma Co., Ltd. · Leukemia, Acute Myeloid (AML), Acute Myeloid Leukemia, Adult

  • CLR 131I-131-CLR1404, Iopofosine I 131 single dosePhase 32 trials

    Cellectar Biosciences, Inc. · Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia

  • CobolimabPhase 32 trials

    GSK · Melanoma, Hodgkin Lymphoma, High and Low Grade Glioma

  • CrenolanibPhase 32 trials

    Arog Pharmaceuticals, Inc. · Newly Diagnosed FLT3 Mutated AML, Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations

  • DersimelagonMT-7117Phase 32 trials

    Tanabe Pharma America, Inc. · EPP, XLP, Erythropoietic Protoporphyria (EPP)

  • DISC-1459Bitopertin, RO4917838Phase 32 trials

    Disc Medicine, Inc · Erythropoietic Protoporphyria, Erythropoietic Protoporphyria (EPP), X-Linked Protoporphyria (XLP)

  • Equecabtagene AutoleucelFUCASOPhase 32 trials

    Nanjing IASO Biotechnology Co., Ltd. · Refractory Immune-mediated Necrotizing Myopathy, Multiple Myeloma

  • GM-CSFPhase 32 trials

    Y-mAbs Therapeutics · Neuroblastoma, Acute Myeloid Leukemia

  • GolidocitinibPhase 32 trials

    Dizal Pharmaceuticals · T-cell Lymphomas, Peripheral T-cell Lymphoma

  • GS1191-0445Phase 32 trials

    Gritgen Therapeutics Co., Ltd. · Severe Hemophilia A, Hemophilia A

  • HetrombopagPhase 32 trials

    Jiangsu HengRui Medicine Co., Ltd. · Chemotherapy-Induced Thrombocytopenia, Immune Thrombocytopenia

  • HMPL-306Phase 32 trials

    Hutchmed · Acute Myeloid Leukemia, Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation

  • HMPL-523SovleplenibPhase 32 trials

    Hutchmed · Warm Antibody Autoimmune Hemolytic Anemia, Primary Immune Thrombocytopenia (ITP)

  • HS-10382MK-4208, Tern-701Phase 32 trials

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Chronic Myeloid Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Chronic Myeloid Leukemia, Chronic Phase

  • Ifupinostat HydrochlorideBEBT-908, CUDC-908Phase 32 trials

    BeBetter Med Inc · Previously Untreated Peripheral T-Cell Lymphoma, Relapsed/Refractory Diffuse Large B-Cell Lymphoma

  • KITE-753Phase 32 trials

    Gilead Sciences · Relapsed or Refractory Large B-cell Lymphoma, Relapsed and/or Refractory B-cell Lymphoma

  • NeladalkibNVL-655Phase 32 trials

    Nuvalent Inc. · Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive, Locally Advanced Solid Tumor

  • NXT007Zemocimig, RO7589655Phase 32 trials

    Roche (Genentech) · Hemophilia A

  • OSE2101Phase 32 trials

    OSE Immunotherapeutics · Patients With Non-Small Cell Lung Cancer, Solid Advanced Tumor, Lymphoma

  • PORT-77Phase 32 trials

    Portal Therapeutics, Inc. · Erythropoietic Protoporphyria (EPP), X-Linked Protoporphyria (XLP), EPP2

  • Purinostat MesylatePhase 32 trials

    Chengdu Zenitar Biomedical Technology Co., Ltd · Relapsed or Refractory Multiple Myeloma (RRMM), Recurrent and Refractory Diffuse Large B-cell Lymphoma

  • QL0911Phase 32 trials

    Qilu Pharmaceutical Co., Ltd. · Cancer Treatment-Induced Thrombocytopenia, Thrombocytopenia, Immune

  • QLS32015Phase 32 trials

    Qilu Pharmaceutical Co., Ltd. · Relapsed or Refractory Multiple Myeloma

  • QLS4131Phase 32 trials

    Qilu Pharmaceutical Co., Ltd. · Malignant Plasma Cell Neoplasms, Relapsed or Refractory Multiple Myeloma

  • RituxumabPhase 32 trials

    Roche (Genentech) · Diffuse Large B-cell Lymphoma, DLBCL - Diffuse Large B Cell Lymphoma

  • Rondecabtagene autoleucelLYL314Phase 32 trials

    Lyell Immunopharma, Inc. · Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Non-Hodgkin Lymphoma

  • RoxadustatFG-4592, ASP1517Phase 32 trials

    Astellas · Chronic Kidney Disease, Renal Anemia, Myelodysplastic Syndromes

  • SapablursenISIS 702843, ONO-0530Phase 32 trials

    Ono Pharmaceutical Co., Ltd. · Polycythemia Vera, Phlebotomy Dependent Polycythemia Vera

  • SoquelitinibCPI-818Phase 32 trials

    Corvus Pharmaceuticals, Inc. · Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema

NewerPage 2 of 7Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.